mTOR inhibition by everolimus in childhood acute lymphoblastic leukemia induces caspase-independent cell death.
Increasingly, anti-cancer medications are being reported to induce cell death mechanisms other than apoptosis. Activating alternate death mechanisms introduces the potential to kill cells that have defects in their apoptotic machinery, as is commonly observed in cancer cells, including in hematologi...
Main Authors: | Rana Baraz, Adam Cisterne, Philip O Saunders, John Hewson, Marilyn Thien, Jocelyn Weiss, Jordan Basnett, Kenneth F Bradstock, Linda J Bendall |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4094511?pdf=render |
Similar Items
-
Silencer of death domains controls cell death through tumour necrosis factor-receptor 1 and caspase-10 in acute lymphoblastic leukemia.
by: Adam Cisterne, et al.
Published: (2014-01-01) -
Regulation of the bone marrow microenvironment by G-CSF: Effects of G-CSF on acute lymphoblastic leukaemia.
by: Jordan Basnett, et al.
Published: (2017-01-01) -
Targeting mTOR in Acute Lymphoblastic Leukemia
by: Carolina Simioni, et al.
Published: (2019-02-01) -
Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
by: Yim K-L
Published: (2012-07-01) -
Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
by: Camilla Evangelisti, et al.
Published: (2018-06-01)